Genomictree Inc.
KOE: 228760.KQ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- KOSDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Sung-Whan An
- Employees
- 81
- Headquarters
- Daejeon, South Korea
- IPO year
- 2017
- Market cap
- ₩376.1B
- Website
- https://www.genomictree.com
Loading 228760…
Loading profile data…Frequently asked questions about 228760
What does Genomictree Inc. (228760.KQ) do?
Genomictree Inc., a biomarker-based molecular diagnostics company, develops and commercializes molecular diagnostic products for the detection of cancer and various infectious diseases. The company offers EarlyTect C, a screening method for early diagnosis of colorectal cancer; EarlyTect L for detection of epigenetic markers associated with lung...
Where does 228760.KQ trade?
Genomictree Inc. (228760.KQ) trades on the KOSDAQ.
What sector is 228760.KQ in?
Genomictree Inc. (228760.KQ) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Genomictree Inc.?
Sung-Whan An is the chief executive officer of Genomictree Inc. (228760.KQ).
Where is Genomictree Inc. headquartered?
Genomictree Inc. is headquartered in South Korea.
Does 228760.KQ pay a dividend?
Genomictree Inc. (228760.KQ) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 228760.KQ go public?
Genomictree Inc. (228760.KQ) completed its initial public offering in 2017.